FEB 18, 2017 8:38 AM PST

Tagging Unmarked Cancer Cells for Targeted Therapy

WRITTEN BY: Xuan Pham

Using small-molecule sugars, scientists successfully made artificial tags for cancer cells that otherwise blended in with healthy cells. The technique, researchers say, will allow for precise and targeted therapies, especially for cancers that previously evaded treatment because they were good at hiding.

Receptors are small molecular protein tags, often found on the surface of cells. Through the binding of other small molecules, receptors can transmit signals from the outside of the cell to the inside of the cell. Aside from cellular communication, receptors are extremely useful in medicine, as these protein tags allow scientists to target specific cells. For example, many drugs are designed to act on cells that express certain receptors on their surface, while leaving other non-specific cells unharmed.

In the case of some cancers, the cells outsmart targeted therapies by the simple virtue of lacking cell surface receptors. The classic example of receptor-negative cancer is triple-negative breast cancer, which lack three receptors: estrogen, progesterone, and the epidermal growth factor receptor 2 (HER2). Absence of receptors makes the cells unidentifiable to drugs, and these cancers typically don’t respond to therapy.

To mark these cells, researchers from the University of Illinois at Urbana-Champaign and China collaborated on a technique that selectively label cancer cells. In particular, they inserted sugar molecules called azides into cells. Cells that are cancerous then metabolize the sugars, causing the expression of receptors on their surface. These receptors are specific to another molecule called DBCO.

"It's very much like a key in a lock. They are very specific to each other. DBCO and azide react with each other with high specificity. We call it click chemistry. The key question is, how do you put azide just on the tumor?" explained Dr. Jianjun Cheng, the study’s senior author.

To ensure that only azide molecules are inserted and metabolized by cancer cells, Cheng’s team modified the sugar with an enzyme that can only be cleaved by cancer cells. In healthy cells, the sugar has no effect.

With receptors expressed on the surface of cancer cells, drug-loaded DBCO molecules can then be introduced. The lock-and-key mechanism ensures only the cancer cells would receive the drug.

"For the first time, we labeled and targeted tumors with small molecule sugars in vivo, and we used the cancer cell's own internal mechanisms to do it,” said Cheng. Not only was Cheng’s team successful with cell cultures, they were able to claim success in mouse models of triple-negative breast cancer and colon cancer too.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 16, 2020
Cancer
I'm addicted to the sun, are you?
SEP 16, 2020
I'm addicted to the sun, are you?
New research published in the Journal of Investigative Dermatology reports evidence that some people are geneticall ...
SEP 18, 2020
Cancer
Itraconazole: the key is in the dosage
SEP 18, 2020
Itraconazole: the key is in the dosage
Precision medicine specific to a patient’s genetics or immune system is spearheading new paths of cancer treatment ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
Loading Comments...